PPP2R1B: Protein Phosphatase 2 Regulatory Subunit B Beta

A key regulator of cell signaling and tumor suppression

Gene Information Card

Symbol PPP2R1B
Full Name Protein Phosphatase 2 Regulatory Subunit B Beta
Gene Type Protein coding
Chromosomal Location 11q23.1
NCBI Gene ID 5519 ncbi.nlm.nih.gov/gene/5519
Ensembl ID ENSG00000137713
UniProt ID P30154
OMIM ID 603113
HGNC ID 9303
Aliases PR65B, PP2A-Abeta, PP2A PR65-B

Description

PPP2R1B encodes the beta isoform of the A subunit (PR65) of protein phosphatase 2 (PP2A), a major serine/threonine phosphatase involved in cell cycle regulation, growth signaling, and apoptosis. The A subunit serves as a scaffold for the catalytic C subunit and regulatory B subunits. Mutations and altered expression of PPP2R1B are implicated in various cancers, including lung, breast, and colorectal carcinomas.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Lung cancer Loss of heterozygosity and somatic mutations in PPP2R1B disrupt PP2A holoenzyme assembly, impairing tumor suppressor function. PMID: 9660920
Colorectal cancer Mutations in PPP2R1B reduce PP2A activity, promoting Wnt/β-catenin signaling. PMID: 15355999
Breast cancer Decreased PPP2R1B expression correlates with poor prognosis and altered AKT signaling. PMID: 21947055
Hepatocellular carcinoma PPP2R1B mutations found in a subset of tumors, suggesting a role in liver carcinogenesis. PMID: 12007222

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Medium
Liver 6.1 Low
Lung 7.8 Medium
Kidney 9.2 Medium
Testis 15.0 High
Cell Line Expression
Cell Line nTPM Notes
HeLa 10.2 Cervical cancer cell line
A549 8.5 Lung cancer cell line
MCF7 7.9 Breast cancer cell line
HEK293 11.0 Embryonic kidney cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.539G>A (p.Arg180Gln) Missense <1% Impaired binding to regulatory B subunits
c.1123C>T (p.Arg375Trp) Missense <1% Reduced PP2A activity
c.1465_1466del (p.Leu489fs) Frameshift <0.5% Loss of function
c.1A>G (p.Met1Val) Start loss <0.1% Complete loss of protein expression
Mutation functional classification

Loss of Function (LOF)

Most reported mutations in PPP2R1B result in loss of scaffold function, reducing PP2A holoenzyme assembly and activity.

Gain of Function (GOF)

No evidence of gain-of-function mutations in PPP2R1B.

Dominant Negative (DN)

Some missense mutations (e.g., p.Arg180Gln) may act in a dominant-negative manner by sequestering catalytic or regulatory subunits.

Gene Ontology (GO)

• GO:0000159 - protein phosphatase type 2A complex • GO:0005515 - protein binding
• GO:0006470 - protein dephosphorylation • GO:0007165 - signal transduction
• GO:0008283 - cell population proliferation • GO:0043085 - positive regulation of catalytic activity

Pathways

hsa04110 - Cell cycle
hsa04115 - p53 signaling pathway
hsa04310 - Wnt signaling pathway
hsa04010 - MAPK signaling pathway
hsa04151 - PI3K-Akt signaling pathway

Protein Summary

The PPP2R1B protein (PR65 beta) is a 589-amino acid scaffold subunit of PP2A. It contains 15 HEAT repeats that mediate interactions with the catalytic C subunit and various regulatory B subunits. PR65 beta is essential for PP2A holoenzyme stability and substrate specificity. The protein is ubiquitously expressed, with highest levels in testis and brain. Structural alterations due to mutations can disrupt PP2A function, contributing to oncogenic signaling.

Related Products

Product name Cat.No. Species Gene ID
PPP2R1B Knockout HEK293 Cell Line EDJ-KQ395 Human 5519 Details Get a Quote
PPP2R1B Knockout A-549 Cell Line EDJ-KQ18618 Human 5519 Details Get a Quote
PPP2R1B Knockout HCT 116 Cell Line EDJ-KQ18619 Human 5519 Details Get a Quote
PPP2R1B Knockout HeLa Cell Line EDJ-KQ18620 Human 5519 Details Get a Quote
Ppp2r1b Knockout 3T3-Swiss albino Cell Line EDJ-KZ410 Mouse 5519 Details Get a Quote
PPP2R1B Knockout HAP1 Cell Line EDC07950 Human 5519 Details Get a Quote
Displaying Records 1 To 6 Of 6 Records
Contact Us
*
*
*
*
How did you hear about us: